Kenneth Der

机构：Amgen (United States)

发表论文 14 篇 · 总被引 111 次 · h-index 5

代表论文

Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies (2018 · Clinical Cancer Research · 被引 40)
Efficacy and safety of the dual SYK/JAK inhibitor cerdulatinib in patients with relapsed or refractory B‐cell malignancies: Results of a phase I study (2018 · American Journal of Hematology · 被引 31)
A Novel Allosteric Insulin Receptor–Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys (2015 · Journal of Pharmacology and Experimental Therapeutics · 被引 14)
Pharmacokinetics of Human Recombinant Anti-Botulinum Toxin Antibodies in Rats (2019 · Toxins · 被引 12)
The Role of Liver and Kidney on the Pharmacokinetics of a Recombinant Amino Terminal Fragment of Bactericidal/Permeability-Increasing Protein in Rats (1997 · Pharmaceutical Research · 被引 8)
P6208Andexanet alfa reduces betrixaban-induced blood loss in a rabbit liver laceration model of acute bleeding (2017 · European Heart Journal · 被引 4)